Non-alcoholic fatty liver disease: new therapeutic options
The past decades have recorded sustainably high incidence of non-alcoholic fatty liver disease (NAFLD) globally. The disease is more prevalent among people with obesity and diabetes mellitus (DM), dyslipidemia and metabolic syndrome (MS) [3, 4]. NAFLD is an independent nosological unit including a r...
Main Author: | R. G. Myazin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/703 |
Similar Items
-
Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China
by: M. Ch. Semenistaya, et al.
Published: (2018-08-01) -
Практические рекомендации для терапевтов по диагностике и лечению неалкогольной жировой болезни печени
by: Екатерина Владимировна Балукова, et al.
Published: (2022-05-01) -
The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01) -
A NEW APPROACH TO THE DIFFERENTIAL DIAGNOSIS OF NON-ALCOHOLIC AND ALCOHOLIC LIVER DISEASE
by: Ольга Александровна Морозова, et al.
Published: (2022-08-01) -
НЕАЛКОГОЛЬНАЯ ЖИРОВАЯ ДЕГЕНЕРАЦИЯ ПЕЧЕНИ У ЛЮДЕЙ РАЗЛИЧНЫХ ВОЗРАСТНЫХ ГРУПП: СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМУ
by: Яна Вячеславовна Савченко, et al.
Published: (2022-04-01)